 |
6-hydroxymethylacylfulvene |
|---|---|
| Trade Name | |
| Orphan Indication | Histologically confirmed advanced or metastatic pancreatic cancer |
| USA Market Approval | USA |
| USA Designation Date | 1999-04-06 00:00:00 |
| Sponsor | Eisai, Inc.;300 Tice Blvd;Woodcliff Lake, New Jersey, 07677 |
